Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins
Alexander J. Martinko(University of California, San Francisco), James A. Wells(University of California, San Francisco)
Cited by 98
Related Papers
Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins
|Nature Biotechnology|2022|243
Inflammatory Stimuli Regulate Caspase Substrate Profiles
|Molecular & Cellular Proteomics|2010|218
Multiscale photocatalytic proximity labeling reveals cell surface neighbors on and between cells
|Science|2024|113
Ligand-binding domains of nuclear receptors facilitate tight control of split CRISPR activity
|Nature Communications|2016|111
Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers
|Journal of Clinical Investigation|2022|39